bluebird bio, Inc.
THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY

Last updated:

Abstract:

Provided are improved compositions and methods for achieving gene therapy in hematopoietic cells and hematopoietic precursor cells, including erythrocytes, erythroid progenitors, and embryonic stem cells. Also provided are improved gene therapy methods for treating hematopoietic-related disorders. Retroviral gene therapy vectors that are optimized for erythroid specific expression and treatment of hemoglobinopathic conditions are disclosed.

Status:
Application
Type:

Utility

Filling date:

16 Mar 2020

Issue date:

26 Nov 2020